Affinity Biopharma Announced the Completion of its Series B2 Financing Round Exceeding 400 Million Chinese Yuan (CNY) to Accelerate the Development of New Drugs

Anglikang Pharmaceutical and Affinity Biopharma Reached Strategic Cooperation Agreement

Affinity QHL-236 Legutaxel Clinical Trial Granted Approval in Australia

Affinity QHL-236 Legutaxel Clinical Trial Application Granted Implied Permission